Peritoneal carcinomatosis. Ten years of applying the new combined triple therapy. Personal experience;Carcinomatosis peritoneal. Diez años aplicando la nueva triple terapia combinada. Experiencia personal

Cirugia Espanola

Volumn 82, Issue 6, 2007, Pages 346-351

  Gómez Portilla, Alberto ^a  

^a Programa de Carcinomatosis Peritoneal   (Spain)

Author keywords

Cytoreductive surgery; Hyperthermia; Perioperative intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

EID: 37149052957     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(07)71745-1     Document Type: Article

References (27)

1. Sticca RP. Peritoneal carcinomatosis: A final frontier. Ann Surg Oncol. 2003;10:484-5.
2. Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Myers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery. 1985;98:414-21.
3. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29:42-7.
4. Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am. 2003;12:703-27.
5. Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon's role. Langenbeck's Arch Surg. 1999;384:576-87.
6. Glehen O, Kwiatkoski M, Sugarbaker PH, Elias D, Levine EA, Gilly FN, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoineal carcinomatosis from colorectal cancer. A multi-institutional study of 506 patients. J Clin Oncol. 2004;22:284-329.
7. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, et al. Hypoerthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg. 1991;15:530-6.
8. Witkamp AJ, De Bree E, Kaag MM, Van Slooten GW, Van Coervorden F, Zoetmulder FAN. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg. 2001;88:458-63.
9. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, et al. Curative Treatment of Peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92:71-6.
10. Cavaliere F, Perri P, Di Filippo F, Giannarelli D, Botti C, Cosimelli M, et al. Treatment of peritoneal carcinomatosis with intent of cure. J Surg Oncol. 2000;74:41-4.
11. Gómez Portilla A, Sugarbaker PH. Segunda cirugía (second look) después de citorreducción y quimioterapia intraperitoneal en la carcinomatosis por cáncer colorrectal: análisis de factores pronósticos. Cir Esp. 1997;61:240-5.
12. Gómez Portilla A, Sugarbaker PH, Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognosis features. World J Surg. 1999;23:23-9.
13. Jaquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49-58.
14. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery. Manual for physicians and nurses. Grand Rapids, Michigan: The Luddann Company; 1995.
15. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol. 1998;14:254-61.
16. Sugarbaker PH. Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy. Tech Coloproctol. 2005;9:95-103.
17. Elias D, Bonnay M, Puizillou JM, Antoun S, Dermirdjian S, El Otomany A, et al. Heated intra-operative intraepritoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Surg Oncol. 2002;13:267-72.
18. Elias D, El Otomany A, Bonnay M, Paci A, Duvreux M, Antoun S, et al. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic. Solutions after complete resection of peritoneal carcinomatosis. Oncology. 2002;63:346-52.
19. Elias D. Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. Surg Oncol Clin N Am. 2003;12:755-69.
20. Elias D, Sideris L, Pocard M, Ede C, Ben Hassouna D, Ducrex M, et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol. 2004;15:781-5.
21. Elias D, Raynard B, Bonnay M, Pocard M. Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies. EJSO. 2006;32:607-13.
22. Verwaal VJ, Van Ruth S, De Bree E, Van Sloothen GW, Van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-43.
23. Verwaal VJ, Van Ruth S, Witkamp A, Boot H, Van Sloothen GW, Zoetmulder FAN. Long term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005;12:65-71.
24. Jacquet P, Stephens A, Averbach A, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77:2622-9.
25. Stephens A, Alderman R, Chang D, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790-6.
26. Witkamp AJ, De Bree E, Kaag MM. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patinets with peritoneal cracinomatosis of colorectal origin. Eur J Cancer. 2001;37:979-84.
27. Sugarbaker PH. Management of peritoneal surface malignancy. Preface. Surg Oncol Clin N Am. 2003;12:xxi-xxiv.